Cargando…

FOXP3, a novel glioblastoma oncosuppressor, affects proliferation and migration

The transcription factor FOXP3 plays an essential role in regulatory T cell development and function. In addition, it has recently been identified as a tumor suppressor in different cancers. Here, we report that FOXP3 is expressed in normal brain but strongly down-regulated in glioblastoma (GB) and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Frattini, Véronique, Pisati, Federica, Speranza, Maria Carmela, Poliani, Pietro Luigi, Frigé, Gianmaria, Cantini, Gabriele, Kapetis, Dimos, Cominelli, Manuela, Rossi, Alessandra, Finocchiaro, Gaetano, Pellegatta, Serena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2012
Materias:	Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717952/ https://www.ncbi.nlm.nih.gov/pubmed/23888189

Ejemplares similares

NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma
por: Speranza, Maria Carmela, et al.
Publicado: (2012)

The multidrug-resistance transporter Abcc3 protects NK cells from chemotherapy in a murine model of malignant glioma
por: Pessina, Sara, et al.
Publicado: (2015)

Immunotherapy against the radial glia marker GLAST effectively triggers specific antitumor effectors without autoimmunity
por: Cantini, Gabriele, et al.
Publicado: (2012)

MET inhibition overcomes radiation resistance of glioblastoma stem‐like cells
por: De Bacco, Francesca, et al.
Publicado: (2016)

Frequency of NFKBIA deletions is low in glioblastomas and skewed in glioblastoma neurospheres
por: Patanè, Monica, et al.
Publicado: (2013)

A Radial Glia Gene Marker, Fatty Acid Binding Protein 7 (FABP7), Is Involved in Proliferation and Invasion of Glioblastoma Cells
por: De Rosa, Antonella, et al.
Publicado: (2012)

PTX3 acts as an extrinsic oncosuppressor
por: Bonavita, Eduardo, et al.
Publicado: (2015)

Restoring the oncosuppressor activity of microRNA-34a in glioblastoma using a polyglycerol-based polyplex
por: Ofek, Paula, et al.
Publicado: (2016)

Intrinsic S phase checkpoint enforced by an antiproliferative oncosuppressor cytokine
por: Mallucci, Livio, et al.
Publicado: (2021)

DNA Damage in Mammalian Neural Stem Cells Leads to Astrocytic Differentiation Mediated by BMP2 Signaling through JAK-STAT
por: Schneider, Leonid, et al.
Publicado: (2013)

ABCC3 Expressed by CD56(dim) CD16(+) NK Cells Predicts Response in Glioblastoma Patients Treated with Combined Chemotherapy and Dendritic Cell Immunotherapy
por: Pellegatta, Serena, et al.
Publicado: (2019)

Updates on HIPK2: a resourceful oncosuppressor for clearing cancer
por: D’Orazi, Gabriella, et al.
Publicado: (2012)

Oncosuppressors and Oncogenes: Role in Haemangioma Genesis and Potential for Therapeutic Targeting
por: Mabeta, Peace
Publicado: (2018)

Transcriptomic landscape of TIMP3 oncosuppressor activity in thyroid carcinoma
por: Mazzoni, M., et al.
Publicado: (2022)

PGE(2) Is Crucial for the Generation of FAST Whole- Tumor-Antigens Loaded Dendritic Cells Suitable for Immunotherapy in Glioblastoma
por: Nava, Sara, et al.
Publicado: (2020)

Axl-Targeted Delivery of the Oncosuppressor miR-137 in Non-small-Cell Lung Cancer
por: Nuzzo, Silvia, et al.
Publicado: (2019)

Oncosuppressor-Mutated Cells as a Liquid Biopsy Test for Cancer-Screening
por: Abdouh, Mohamed, et al.
Publicado: (2019)

Epigenetic regulation of the extrinsic oncosuppressor PTX3 gene in inflammation and cancer
por: Rubino, Marcello, et al.
Publicado: (2017)

Advanced MRI Assessment during Dendritic Cell Immunotherapy Added to Standard Treatment against Glioblastoma
por: Cuccarini, Valeria, et al.
Publicado: (2019)

EBF1 is expressed in pericytes and contributes to pericyte cell commitment
por: Pagani, Francesca, et al.
Publicado: (2021)

The natural killer cell response and tumor debulking are associated with prolonged survival in recurrent glioblastoma patients receiving dendritic cells loaded with autologous tumor lysates
por: Pellegatta, Serena, et al.
Publicado: (2013)

Leptomeningeal dissemination of anaplastic medullary cone astrocytoma: an unexpected findings in a patient with leptomeningeal enhancement and clinical history of multiple myeloma
por: Daffini, Linda, et al.
Publicado: (2021)

An Optimized Method for Manufacturing a Clinical Scale Dendritic Cell-Based Vaccine for the Treatment of Glioblastoma
por: Nava, Sara, et al.
Publicado: (2012)

Glioblastomas
por: Finocchiaro, Gaetano, et al.
Publicado: (2021)

The integrated landscape of driver genomic alterations in glioblastoma
por: Frattini, Veronique, et al.
Publicado: (2013)

A Commentary on “PTX3 is an Extrinsic Oncosuppressor Regulating Complement-Dependent Inflammation in Cancer”
por: Di Virgilio, Francesco
Publicado: (2015)

microRNA‐377‐3p downregulates the oncosuppressor T‐cadherin in colorectal adenocarcinoma cells
por: Di Palo, Armando, et al.
Publicado: (2021)

Lactotroph PitNET/adenoma associated to granulomatous hypophysitis in a patient with Crohn's disease: A case report
por: Pietrantoni, Alberto, et al.
Publicado: (2022)

Chromosomal localisation of two putative 11p oncosuppressor genes involved in human ovarian tumours.
por: Viel, A., et al.
Publicado: (1992)

RB1-mediated cell-autonomous and host-dependent oncosuppressor mechanisms in radiation-induced osteosarcoma
por: Kansara, Maya, et al.
Publicado: (2014)

Prognostic Value of CD109+ Circulating Endothelial Cells in Recurrent Glioblastomas Treated with Bevacizumab and Irinotecan
por: Cuppini, Lucia, et al.
Publicado: (2013)

Timing of mTOR activation affects tuberous sclerosis complex neuropathology in mouse models
por: Magri, Laura, et al.
Publicado: (2013)

Treatment with anti-FcεRIα antibody exacerbates EAE and T-cell immunity against myelin
por: Musio, Silvia, et al.
Publicado: (2017)

A novel oncogenic role for urokinase receptor in leukemia cells: molecular sponge for oncosuppressor microRNAs
por: Li Santi, Anna, et al.
Publicado: (2018)

KCTD15 inhibits the Hedgehog pathway in Medulloblastoma cells by increasing protein levels of the oncosuppressor KCASH2
por: Spiombi, Eleonora, et al.
Publicado: (2019)

The many facets of miR‐223 in cancer: Oncosuppressor, oncogenic driver, therapeutic target, and biomarker of response
por: Favero, Andrea, et al.
Publicado: (2021)

Direct Interaction of miRNA and circRNA with the Oncosuppressor p53: An Intriguing Perspective in Cancer Research
por: Bizzarri, Anna Rita, et al.
Publicado: (2021)

Exceptionally rare IDH1-mutant adult medulloblastoma with concurrent GNAS mutation revealed by in vivo magnetic resonance spectroscopy and deep sequencing
por: Liserre, Roberto, et al.
Publicado: (2023)

DEAD-Box RNA Helicases DDX3X and DDX5 as Oncogenes or Oncosuppressors: A Network Perspective
por: Secchi, Massimiliano, et al.
Publicado: (2022)

Altered Metabolism in Glioblastoma: Myeloid-Derived Suppressor Cell (MDSC) Fitness and Tumor-Infiltrating Lymphocyte (TIL) Dysfunction
por: Di Ianni, Natalia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kbt1d0i3bm8qs5l959a1eem4h7